Where is GSK headquartered?
GSK is headquartered in London, United Kingdom.
Gain a deeper understanding of how GSK is organized around the world. Founded in 1999, GSK operates a network of 703 subsidiaries across 84 countries, with 269 in the United States (38.3%), 112 in the United Kingdom (15.9%), and 30 in Japan (4.3%). Together these three countries account for 58.5% of the companies owned by GSK.
GSK
Company Hierarchy
| Company | Location | Founded | Employees | Revenue (USD) | Legal Type | CEO | Website | Category Code | Category Description | # in Group | Local HQ Name | Local HQ City | Local HQ Country | National HQ Name | National HQ City | Global HQ Name | Global HQ City | Global HQ Country | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gsk PLCGsk PLCGlobal Headquarter | Holborn, Unitedkingdom | 1999 | 68,307 | $43.2B | Corporation | Elizabeth Mckee Anderson | gsk.com | 6719 | Offices of Holding Companies, Not Elsewhere Classified | 703 | GSK PLC | LONDON | England | GSK PLC | LONDON | GSK PLC | LONDON | England | ||
Ucb Pharma Asia Pacific Sdn BHDUcb Pharma Asia Pacific Sdn BHD | Kuala Lumpur, Malaysia | 2004 | 40 | $5.4M | Corporation | Kok Wee Kiat | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | GLAXOSMITHKLINE PHARMACEUTICAL SDN. BHD. | Petaling Jaya | Malaysia | GLAXOSMITHKLINE PHARMACEUTICAL SDN. BHD. | Petaling Jaya | GSK PLC | LONDON | England | |||
Gsk Vaccines Institute For Global Health SRLGsk Vaccines Institute For Global Health SRLNational HQ | Siena, Italy | 2007 | 86 | $37.3M | Corporation | Yannick Vanloubbeeck | gsk.com | 8731 | Commercial Physical and Biological Research | 703 | SETFIRST LIMITED | LONDON | England | GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL | SIENA | GSK PLC | LONDON | England | ||
Glaxosmithkline Trading Services LIMITEDGlaxosmithkline Trading Services LIMITEDNational HQ | Dublin, Ireland | 2005 | 100 | $17.5B | Corporation | James Mcgrath | 2834 | Pharmaceutical Preparations | 703 | SETFIRST LIMITED | LONDON | England | GLAXOSMITHKLINE TRADING SERVICES LIMITED | DUBLIN | GSK PLC | LONDON | England | |||
Glaxosmithkline Trading Services LIMITEDGlaxosmithkline Trading Services LIMITED | Holborn, Unitedkingdom | 2013 | 525 | $17.5B | Foreign company | Andrew James Collier | gsk.com | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | GLAXOSMITHKLINE TRADING SERVICES LIMITED | DUBLIN | Ireland | GSK PLC | LONDON | GSK PLC | LONDON | England | ||
Glaxosmithkline Ecuador S.A.Glaxosmithkline Ecuador S.A.National HQ | Quito, Ecuador | 1984 | 123 | $41.7M | Corporation | Carlos Eduardo Araoz Morato | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | SETFIRST LIMITED | LONDON | England | Glaxosmithkline Ecuador S.A. | Quito | GSK PLC | LONDON | England | |||
Glaxosmithkline Ecuador S.A.Glaxosmithkline Ecuador S.A. | Guayaquil, Ecuador | Cesar Guerra | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | Glaxosmithkline Ecuador S.A. | Quito | Ecuador | Glaxosmithkline Ecuador S.A. | Quito | GSK PLC | LONDON | England | |||||||
Haleon Consumer Healthcare Mexico, S. De R.L. De C.V.Haleon Consumer Healthcare Mexico, S. De R.L. De C.V. | Jiutepec, Mexico | 292 | Cecilia Rios Penuelas | haleon.com | 2834 | Pharmaceutical Preparations | 703 | Haleon Consumer Healthcare Mexico, S. de R.L. de C.V. | Mexico | Mexico | Haleon Consumer Healthcare Mexico, S. de R.L. de C.V. | Mexico | GSK PLC | LONDON | England | |||||
Stiefel Laboratories INCStiefel Laboratories INCNational HQ | Santiago, Chile | 1993 | 2 | $312K | Corporation | 6719 | Offices of Holding Companies, Not Elsewhere Classified | 703 | GSK PLC | LONDON | England | Stiefel Laboratories Inc | SANTIAGO | GSK PLC | LONDON | England | ||||
Stiefel Laboratories Ireland LTDStiefel Laboratories Ireland LTD | Santiago, Chile | 1993 | 2 | $312K | Partnership of unknown type | 6719 | Offices of Holding Companies, Not Elsewhere Classified | 703 | Stiefel Laboratories Inc | SANTIAGO | Chile | Stiefel Laboratories Inc | SANTIAGO | GSK PLC | LONDON | England | ||||
Glaxo Smithkline TunisieGlaxo Smithkline TunisieNational HQ | Tunis Ville, Tunisia | 2000 | $6.3M | Corporation | 9999 | Nonclassifiable Establishments | 703 | SETFIRST LIMITED | LONDON | England | GLAXO SMITHKLINE TUNISIE | TUNIS VILLE | GSK PLC | LONDON | England | |||||
Smithkline Beecham Egypt LLCSmithkline Beecham Egypt LLCNational HQ | Giza, Egypt | 1997 | 450 | $48.3M | Corporation | Sami Michel | 2834 | Pharmaceutical Preparations | 703 | GSK PLC | LONDON | England | SMITHKLINE BEECHAM EGYPT LLC | Giza | GSK PLC | LONDON | England | |||
Glaxo Wellcome (kenya) LIMITEDGlaxo Wellcome (kenya) LIMITEDNational HQ | Nairobi, Kenya | 70 | $7.5M | 2834 | Pharmaceutical Preparations | 703 | GSK PLC | LONDON | England | Glaxo Wellcome (Kenya) Limited | Nairobi | GSK PLC | LONDON | England | ||||||
Glaxosmithkline Pharmaceutical Nigeria LTDGlaxosmithkline Pharmaceutical Nigeria LTDNational HQ | Apapa, Nigeria | 1994 | 183 | $19.3M | Corporation | Lekan Asuni | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | GSK PLC | LONDON | England | GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD | Apapa | GSK PLC | LONDON | England | |||
Glaxosmithkline Paraguay S.A.Glaxosmithkline Paraguay S.A.National HQ | Orilla del Campo Grande, Paraguay | 26 | $2.4M | Corporation | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | GSK PLC | LONDON | England | GLAXOSMITHKLINE PARAGUAY S.A. | Campo Grande | GSK PLC | LONDON | England | |||||
Tesaro, INC.Tesaro, INC.National HQ | Waltham, USA | 2010 | 715 | $19.4M | Corporation | Leon O Moulder Jr | us.gsk.com | 2834 | Pharmaceutical Preparations | 703 | GSK PLC | LONDON | England | TESARO, Inc. | WALTHAM | GSK PLC | LONDON | England | ||
Tesaro Securities CORPORATIONTesaro Securities CORPORATION | Waltham, USA | 2012 | 583 | $944K | Corporation | Gregory Covino | us.gsk.com | 2834 | Pharmaceutical Preparations | 703 | Tesaro, Inc. | WALTHAM | United States of America | TESARO, Inc. | WALTHAM | GSK PLC | LONDON | England | ||
Glaxosmithkline Uruguay S.A.Glaxosmithkline Uruguay S.A.National HQ | Montevideo, Uruguay | 1941 | 25 | $2.3M | Corporation | Martín Arregui | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | SETFIRST LIMITED | LONDON | England | GLAXOSMITHKLINE URUGUAY S.A. | Montevideo | GSK PLC | LONDON | England | |||
Shanghai Gelan Sushike Pharmaceuticals CO., LTD.Shanghai Gelan Sushike Pharmaceuticals CO., LTD.National HQ | Shanghai, China | 2024 | 50 | $5.4M | Foreign company | Yan Zhang | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | SETFIRST LIMITED | LONDON | England | Shanghai Gelan Sushike Pharmaceuticals Co., Ltd. | Shanghai | GSK PLC | LONDON | England | |||
Glaxosmithkline Chile Farmaceutica LimitadaGlaxosmithkline Chile Farmaceutica LimitadaLocal HQ | Santiago, Chile | 2005 | 235 | $19.5M | Partnership of unknown type | Juan Carlos Corbeaux | 2834 | Pharmaceutical Preparations | 703 | Setfirst Limited | SANTIAGO | Chile | Setfirst Limited | SANTIAGO | GSK PLC | LONDON | England | |||
Glaxosmithkline Chile Farmaceutica LimitadaGlaxosmithkline Chile Farmaceutica Limitada | Santiago, Chile | 2005 | 120 | Juan Carlos Cordeau | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 703 | Glaxosmithkline Chile Farmaceutica Limitada | SANTIAGO | Chile | Setfirst Limited | SANTIAGO | GSK PLC | LONDON | England | |||||
Human Genome Sciences, INC.Human Genome Sciences, INC. | Rockville, USA | 256 | William Hastline | 2834 | Pharmaceutical Preparations | 703 | Human Genome Sciences, Inc. | ROCKVILLE | United States of America | Human Genome Sciences, Inc. | ROCKVILLE | GSK PLC | LONDON | England | ||||||
Glaxosmithkline PLCGlaxosmithkline PLCNational HQ | Philadelphia, USA | 60 | Viehbacher Christopher | 2834 | Pharmaceutical Preparations | 703 | GSK PLC | LONDON | England | GlaxoSmithKline PLC | PHILADELPHIA | GSK PLC | LONDON | England | ||||||
Gsk Vaccines RockvilleGsk Vaccines RockvilleNational HQ | Rockville, USA | 2015 | 28 | $13.9M | gsk.com | 2834 | Pharmaceutical Preparations | 703 | GSK PLC | LONDON | England | GSK VACCINES ROCKVILLE | Rockville | GSK PLC | LONDON | England | ||||
Novartis Vaccines And Diagnostics, INC.Novartis Vaccines And Diagnostics, INC.National HQ | Holly Springs, USA | 2015 | 5,500 | $50.1M | Corporation | Joerg Reinhardt | novartis.com | 2835 | In Vitro and In Vivo Diagnostic Substances | 703 | GSK PLC | LONDON | England | Novartis Vaccines And Diagnostics, Inc. | HOLLY SPRINGS | GSK PLC | LONDON | England | ||
Get 1,000 subsidiaries free
GSK’s ownership network is one of more than 41 million corporate hierarchies in our company ownership database. It maps parent companies, subsidiaries and ultimate beneficial owners (UBO), showing how companies are structured and who owns whom, with verified data across 200 countries and jurisdictions. Explore how the dataset works and request a tailored sample.
GSK is headquartered in London, United Kingdom.
Yes, GSK plc is publicly listed on the London Stock Exchange.
GSK employs tens of thousands of people globally.
The United States (278), United Kingdom (116), China (14), and India (9) have the highest numbers of GSK subsidiaries.
Global data. Local insights.
Explore more about global corporate data, subsidiaries, and company hierarchies in our recent blog posts.
A global ultimate in a corporate family refers to the highest-level parent company in a...
Company Registries in the EU & North America A practical guide for compliance, KYC and...
What Are Company Family Members? A company family members refers to a group of interrelated...
Corporate family tree
Knowing who owns a company is essential to understanding how businesses link and function worldwide. Our corporate hierarchy data allows you to follow connections between parent companies, subsidiaries, and shareholders, revealing control, organization, and potential risks within any global corporate group. Whether you are investigating GSK or another multinational, these insights aid compliance, market research, and better CRM management. With verified ownership records covering over 380 million companies around the globe, CompanyData.com gives you a clear view of corporate ownership across industries and countries.
At CompanyData.com, every company profile such as GSK is organized using our three-tier hierarchy model: Global, National, and Local headquarters. This structure clarifies how each entity fits inside the larger corporate group.
Each company gets a unique ID, enabling you to connect subsidiaries to their parent companies, trace ownership paths, and merge data into your systems.
Control is based on ownership stakes. When a company holds more than 50% of another, we mark it as a controlled subsidiary. Our data highlights these majority-owned relationships to clearly represent corporate structures. This method gives a transparent view of complex groups like GSK’s and can be applied to any multinational business.
This hierarchy helps identify who truly controls the GSK Group, simplifies compliance checks, and supports mergers, acquisitions, and risk management. By mapping each entity with verified ownership data, CompanyData.com lets you explore GSK’s corporate setup with confidence. With over 41 million companies linked in 200 countries and regions, our platform offers clarity for teams working with multinational groups.

CompanyData.com supports global organizations that need verified insights into corporate ownership structures, from CRM enrichment and compliance workflows to market intelligence and analytics. We provide free evaluation samples; larger data samples (for example, up to 1,000 companies) are available to qualified corporate buyers with a defined use case and an active company website. If your primary need is contact or lead lists, please visit our Company Data Platform instead.
Tell us about your use case or data challenge, and our team will send you a tailored ownership data sample within 24 hours.
You can access GSK company data through API, bulk files, or the Bold Platform. We create custom datasets based on your target countries, industries, and company profiles. After you share your criteria, our experts prepare a tailored dataset and send a free quote with record counts and sample data within 24 hours. Once approved, we deliver your data quickly in your preferred format — via Excel, API, bulk file, or directly in the Bold Platform.
If you need company data from any organization or industry, CompanyData.com provides complete global coverage. You’ll get accurate, verified business information across every country and sector. Simply tell us what you’re looking for, and our experts will prepare a custom dataset that fits your goals. Within 24 hours, you’ll receive a free quote, record count, and sample data. Once approved, we deliver your data fast — via Excel, API, bulk file, or directly in the Bold Platform.
The price of our GSK company data varies based on your chosen details and delivery method. Whether you need a list of subsidiaries or a full dataset via API or bulk files, we offer flexible pricing to suit your needs. You can request a free quote and record count within 24 hours — our team will provide transparent pricing and a free sample of 10 company contacts. At CompanyData.com, you only pay for the verified global data you need.
At CompanyData.com, we offer secure and flexible payment options for purchasing company data, including credit cards, bank transfer, and PayPal. All payments are processed safely, and invoices are provided. For larger or ongoing access, we also support subscription billing and custom invoicing. Need a special arrangement? Contact our sales team — we’re happy to help.
At CompanyData.com, you can access detailed, verified data on GSK plc and all its subsidiaries, updated daily. This includes company names, registration details, locations, industry classifications, financial indicators, and key contacts. You can download the data via the Bold Platform, API, or bulk file delivery. Our database offers 100% worldwide company coverage, ensuring complete and accurate insights.
At CompanyData.com, our data comes from verified global business sources to ensure accuracy and full coverage. We combine official registers, financial filings, LEI records, trusted partners, and verified company websites. All data is cross-checked and validated by our experts, ensuring it’s accurate, up-to-date, and GDPR-compliant.
Tell us your target group, and we’ll send you a free quote and a tailored company ownership dataset — sample included. Call +31 20 705 236 or email sales@companydata.com. Ready to order? Simply reply to the quote, and CompanyData.com delivers your dataset in CSV or Excel within 24 hours.